Bridging the Gap: Conference Workbook [International Conference on AIDS (12th: 1994: Geneva, Switzerland)]

Monday, June 29

POTE SESIN Trc C 130-32

13303 The effects of antiretroviral therapy and year of AIDS diagnosis on
survival
A.D. McNaghten*; D.L. Hanson;.L. Jones; M.S. Dworkin; J. W. Ward, USA
13304 Lack of evidence for a role of the CCR5 D 32 deletion mutation on disease
progression in HIV-infected injecting drug users
Janke Schinkel*; M. W Langendam; R.A. Coutinho; A. Krol; M. Brouwer;
H. Schuitemaker, The Netherlands
13305 Production of b-Chemokines in HIV-infection:
Levels of MIP-1 b are predictive to the risk of HIV disease progression
Henrik Ullum*; A. Cozzi Lepri; J. Victor; H. Alladin; A.N. Phillips;
P. Skinhej; B.K. Pedersen, UK
13306 Hepatitis C virus (HCV) genotypes and progression of HIV-infection in
hemophiliacs
Angelos Hatzakis*; G. Touloumi; A. Karafoulidou; T. Mandalaki;
JJ. Goedert, Greece, USA
13307 Timeto AIDS diagnosis increased in 1996, when use of highly active
antiviral therapy (HAART) became prevalent
Grant Colfax*; E. Vittinghoff; S.D. Holmberg; S. Buchbinder, USA
13308 Is cell-associated infectious HIV-1 viral load beneficial in predicting
HIV-1 disease progression after knowing plasma HIV-1 RNA level?
Cynthia Lyles*; H. Farzadegan; T.C. Quinn; J. Astemborski; J.B. Margolick;
D. Schaeffer; D. Vlahov, USA
13309 Serum albumin as a predictor of survival in HIV-infected (HIV+) women
enrolled in the Women's Interagency HIV Study (WIHS)
Joseph Feldman*; K. Anastos; P. Bacchetti; D. Burns; M. Cohen;
R. Delapenha; P. Miotti, USA
13310 HHV-8 seropositivity and risk of developing Kaposi's sarcoma (KS) and
other AIDS-related diseases among individuals with known dates of HIV
seroconversion
Giovanni Rezza*; M. Dorrucci; P. Pezzotti; M. Andreoni; B. Ensoli, Italy
13311 Chemokine receptor genotypes and HIV disease progression:
A preliminary meta-analysis
John P.A. loannidis*; D.G. Contopoulos-loannidis, USA
13312 Evidence from the Australian Ashkenazi Jewish population suggests an
eastern European Ashkenazi origin of CCRS-A32 D32
Marc Buhler*; A. Proos; V. Howell; B. Bennetts; L. Burnett; G. Stewart,
Australia
13313 HIV disease progression following newly acquired HIV-infection in
Australia, 1991-1997
Ann McDonald*" J. Cui; J.M. Kaldor, Australia
13314 Comparison of viral load levels between cohorts infected with HIV-1
subtypes Band C
Noya Galai*; E. Shahar; O. Naor; A. Barzilai; S. Pollack; A. Kalinkovich;
Z. Bentwich, Israel
13315 Impact of pulmonary tuberculosis (TB) on survival of HIV-infected
Ugandan adults
Peter Nsubuga*; A. Okwera; J. L.Johnson; R. Mugerwa;J. EI/ner;
C. Whalen, Uganda
13316 Serial CD4 Counts following HIV seroconversion in a male factory cohort
Rhoderick Machekano*; Pepsi Zhou;Trevor Nyamurera; Mary Bassett;
David Katzenstein, Zimbabwe

13317 Definition of T-cell lymphocyte inflection and prevalence by AIDS
defining diagnoses
Stephen Gange*; A. Munoz; J.S. Chmiel; A.D. Donnenberg; R. Detels;
J.B. Margolick, USA
13318 Impact of highly active antiretroviral therapy (HAART) on
CD4 lymphocyte counts in France
Anne Laporte* I. Villadary; J. Pillonel; F. Lot; P. Gouezel, France
13319 Incidence of Disease after HIV-2 infection as compared to HIV-1
infection
RichardMarlink* S. Mboup; I. Thior; I. Traore; M. Essex; I. Ndoye;
P Kanki, USA
13320 Effect of mannose-binding lectin variant alleles on HIV-1 disease
progression in 426 patients with a known date of infection
Nagdalena Nagierowcka*; J.B. Hubert; P. Dembre; C. Rouzioux;
J.F. Delfraissy; L. Neyer; I. Theodorn, France
13321 Amsterdam cohort study: Presence of the variant Mannose-Binding
Lectin (MBL) alleles associated with slower progression to AIDS?
Jlaap Maas*; A.M. De Roda Husman; M. Brouwer; A. Krol; R.A. Coutinho;
I.P.M. Keet; H. Schuitemaker, The Netherlands
13322 Patterns of longitudinal HIV-1 viral load after seroconversion associated
with HIV-1 disease progression among injection drug users
Cynthia Lyles*;J. Astemborski; T.C Quinn; T.R. Sterling; T. Freedman;
D. Vlahov, USA
13323 Temporal changes on the rate of progression to AIDS in the HIV-Italian
seroconversion study (ISS)
Maria Dorrucci*" P. Pezzotti; M.B. Alliegro; G. Rezza, Italy
13324 Survival of healthy HIV-infected skin-test anergic and non-anergic adults
from a voluntary counselling and testing clinic in Kampala, Uganda
Peter Nsubuga*" A. Okwera; J.L. Johnson; C. Whalen; R. Mugerwa;
J. Ellner, Uganda
13325 Risk factors for progression to primary and subsequent AIDS diagnoses in
the Tricontinental Seroconverter Study
Birgit Van Benthem*; K.A. Page-Shafer; M. T Schechter; J.M. Kaldor;
R.A. Coutinho; G.J.P Van Griensven, The Netherlands
13326 CD4 cell count and viral load in HTLV-II and HIV coinfection in injection
drug users
David Vlahov*; Hong Zhang; C. Flynn; K.E. Nelson; D. Vlahov, US
NOTES

CONFERENCE WORKBOOK

47